Marcelo Cantarovich, MD
Primary Axis:
Infection and Immunity
Email:
Email contact form Research Focus:
Optimizing the use of immunosuppressive medications, optimization of the assessment of renal function and development of renal protective strategies in solid-organ transplant patients.Cyclosporine, tacrolimus, nephrotoxicity, renal function, pharmacokinetics
Keywords:
Cyclosporine, tacrolimus, nephrotoxicity, renal function, pharmacokinetics
Location:
Royal Victoria Hospital Publications:
Cantarovich M, Metrakos P, Giannetti N, Barkun J, Cecere R, Tchervenkov J. Anti-CD25 monoclonal antibody coverage allows for calcienurin inhibitor holiday in solid organ transplant patients with acute renal dysfunction. Transplantation 2002; 73:1169-1172.
Cantarovich M, Barkun J, Tchervenkov JI, Besner JG, Aspeslet L, Metrakos P. Comparison of Neoral dose monitoring with cyclosporine trough levels versus 2-hour post-dose levels in stable liver transplant patients. Transplantation 1998; 66:1621-1627.
Cantarovich M, Besner JG, Barkun J, Elstein E, Loertscher, R. Two hour Cyclosporine level determination is the appropriate tool to monitor Neoral therapy. Clinical Transplantation 1998; 12:243-249.
